Financials data is unavailable for this security.
View more
Year on year Zhejiang Gongdong Medical Technology Co Ltd 's revenues fell -33.61% from 1.47bn to 975.08m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 326.05m to 109.13m, a -66.53% decrease.
Gross margin | 32.48% |
---|---|
Net profit margin | 14.77% |
Operating margin | 16.32% |
Return on assets | 8.40% |
---|---|
Return on equity | 9.89% |
Return on investment | 9.71% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Zhejiang Gongdong Medical Technology Co Ltd fell by 305.56m. However, the company earned 185.39m from its operations for a Cash Flow Margin of 19.01%. In addition the company used 397.43m on investing activities and also paid 95.80m in financing cash flows.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 10.57 |
---|---|
Tangible book value per share | 8.34 |
More ▼
Balance sheet in CNYView more
Current ratio | 3.40 |
---|---|
Quick ratio | 3.00 |
Total debt/total equity | 0.0553 |
---|---|
Total debt/total capital | 0.0521 |
More ▼
Growth rates in CNY
Year on year, growth in dividends per share increased 166.67% while earnings per share excluding extraordinary items fell by -66.67%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg) | -- |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 20.82% |
EPS growth(5 years) | -0.8252 |
---|---|
EPS (TTM) vs TTM 1 year ago | 52.34 |
More ▼